Korenaga Y - Search Results

1

[Successful treatment with rituximab for type III cryoglobulinemia].

Suehiro Y, Ishido A, Shigeoka T, Tominaga T, Korenaga Y, Yamamoto M, Takahashi T. Suehiro Y, et al. Among authors: korenaga y. Rinsho Ketsueki. 2015 Feb;56(2):220-4. doi: 10.11406/rinketsu.56.220. Rinsho Ketsueki. 2015. PMID: 25765804 Japanese.

2

Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma.

Kawai Y, Sakano S, Suehiro Y, Okada T, Korenaga Y, Hara T, Naito K, Matsuyama H, Hinoda Y. Kawai Y, et al. Among authors: korenaga y. Ann Oncol. 2010 Aug;21(8):1612-1617. doi: 10.1093/annonc/mdp577. Epub 2009 Dec 27. Ann Oncol. 2010. PMID: 20038516 Free article.

3

The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.

Sakano S, Hinoda Y, Okayama N, Kawai Y, Korenaga Y, Eguchi S, Nagao K, Ohmi C, Naito K. Sakano S, et al. Among authors: korenaga y. Ann Oncol. 2007 Nov;18(11):1817-27. doi: 10.1093/annonc/mdm337. Epub 2007 Aug 21. Ann Oncol. 2007. PMID: 17712032 Free article.

4

Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma.

Korenaga Y, Naito K, Okayama N, Hirata H, Suehiro Y, Hamanaka Y, Matsuyama H, Hinoda Y. Korenaga Y, et al. Int J Cancer. 2005 Nov 10;117(3):431-4. doi: 10.1002/ijc.21187. Int J Cancer. 2005. PMID: 15906349 Free article.

5

Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.

Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K. Kawai Y, et al. Among authors: korenaga y. Eur Urol. 2007 Oct;52(4):1147-55. doi: 10.1016/j.eururo.2007.01.073. Epub 2007 Jan 30. Eur Urol. 2007. PMID: 17287073

6

Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma.

Kawai Y, Matsuyama H, Korenaga Y, Misumi T, Eguchi S, Hara T, Nagao K, Ohmi C, Sakano S, Naito K. Kawai Y, et al. Among authors: korenaga y. Urol Int. 2009;83(3):306-10. doi: 10.1159/000241673. Epub 2009 Oct 13. Urol Int. 2009. PMID: 19829031

7

Clinical significance of lymph node dissection in renal cell carcinoma.

Matsuyama H, Hirata H, Korenaga Y, Wada T, Nagao K, Yamaguchi S, Yoshihiro S, Naito K. Matsuyama H, et al. Among authors: korenaga y. Scand J Urol Nephrol. 2005;39(1):30-5. doi: 10.1080/00365590410018701. Scand J Urol Nephrol. 2005. PMID: 15764268

8

Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma.

Nagao K, Yamaguchi S, Matsuyama H, Korenaga Y, Hirata H, Yoshihiro S, Fukunaga K, Oba K, Naito K. Nagao K, et al. Among authors: korenaga y. Cancer Genet Cytogenet. 2005 Jul 1;160(1):43-8. doi: 10.1016/j.cancergencyto.2004.11.015. Cancer Genet Cytogenet. 2005. PMID: 15949569

9

Smoking may cause genetic alterations at 5q22.2 approximately q23.1 in clear-cell renal cell carcinoma.

Korenaga Y, Matsuyama H, Hirata H, Nagao K, Ohmi C, Sakano S, Yoshihiro S, Naito K. Korenaga Y, et al. Cancer Genet Cytogenet. 2005 Nov;163(1):7-11. doi: 10.1016/j.cancergencyto.2005.03.015. Cancer Genet Cytogenet. 2005. PMID: 16271949

10

Deletion mapping of 18q in conventional renal cell carcinoma.

Hirata H, Matsuyama H, Matsumoto H, Korenaga Y, Ohmi C, Sakano S, Yoshihiro S, Naito K. Hirata H, et al. Among authors: korenaga y. Cancer Genet Cytogenet. 2005 Dec;163(2):101-5. doi: 10.1016/j.cancergencyto.2005.03.010. Cancer Genet Cytogenet. 2005. PMID: 16337851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page